The Next Generation of Innovative Cardiovascular Clinical/Translational Researchers

下一代创新型心血管临床/转化研究人员

基本信息

  • 批准号:
    10548209
  • 负责人:
  • 金额:
    $ 11.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-01-01 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract My career focus is research and educational efforts to reduce early cardiovascular disease (CVD) risk factors. Obesity, diabetes, and underlying insulin resistance (IR) are major contributors to CVD, accelerated by the current pediatric obesity epidemic. Unique factors in youth with type 2 diabetes (T2D) lead to early insulin dependence and progression of co-morbidities that accelerate CVD and mortality, and typical adult T2D treatments are ineffective in youth. The mechanism of IR in T1D is also unclear, limiting our ability to reduce CVD risk in T1D. Moreover, current CV-assessment tools are often too invasive for youth. My prior research training, initial leadership experiences and collaborations with cardiology, bioengineering, and radiology provide the skills and combined expertise to address these critical voids. An NHLBI K24 grant will train me to better provide mentorship in high-impact POR to CVD-focused physician-scientists of exceptional potential and nurture a diverse pipeline of new investigators. My career goals are to: 1) Better understand early precursors of CVD in the underserved population of youth with obesity/diabetes 2) Develop non-invasive approaches to CVD risk-assessment tolerable to youth 3) Develop new medical and/or surgical treatments to reduce CVD risk in youth and 4) Learn how to best engage, motivate and train a diverse set of emerging researchers in cutting- edge POR. Support as a K24 scholar will provide dedicated time to benefit from the exceptional POR mentoring and leadership training resources of our campus and beyond, and focus on these goals. My K24 application includes an overview of: 1) My skills, record and dedication to mentoring in POR; 2) A strategy to reduce administrative/clinical obligations and focus on mentoring; 3) An impactful, cutting-edge K24 POR proposal with numerous opportunities for trainees; 4) A strategy for integrating expert collaborators as a K24 Advisory Committee to deliver superior and cohesive training, mentoring and oversight of junior colleagues and to assure a pipeline of future trainees; 5) Evidence of a robust pool of protected early career POR investigators to benefit from K24 support; 6) A timeline for training in responsible conduct of research; 7) Evidence of the collaborator, institutional and environmental support underlying my POR program and for the K24 proposal. My Aims as an NHLBI K24 Scholar are to: 1) Strengthen mentoring of a diverse set of early career investigators to create a pipeline of well-trained physician-scientists focused on CVD POR. Rationale: The proposed training plan offers exceptional support, environment and expertise for creating a POR career in CVD prevention. I will integrate my current mentoring skills with those gained from the K24, to deliver the highest quality mentorship. 2). Build upon my CVD risk-reduction POR in youth-onset obesity/diabetes. Rationale: Given K24 support, I am positioned to enhance the quality and breadth of our POR research, and thereby improve the lives of the growing numbers of youth with obesity and diabetes.
项目总结/摘要 我的职业重点是研究和教育工作,以减少早期心血管疾病(CVD)的风险 因素肥胖、糖尿病和潜在的胰岛素抵抗(IR)是CVD的主要原因, 儿童肥胖症的流行2型糖尿病(T2 D)青年患者的独特因素导致早期胰岛素 加速CVD和死亡率的合并症的依赖性和进展,以及典型的成人T2 D 治疗对年轻人无效。T1 D中IR的机制也不清楚,限制了我们减少IR的能力。 T1 D的CVD风险。此外,目前的CV评估工具对年轻人来说往往过于侵入性。我之前的研究 培训、初步领导经验以及与心脏病学、生物工程学和放射学的合作 提供技能和综合专业知识,以解决这些关键的空白。一个NHLBI K24赠款将训练我, 在高影响力POR中,更好地为具有特殊潜力的心血管疾病医生-科学家提供指导, 培养新调查人员的多样化渠道。我的职业目标是:1)更好地了解早期前兆 2)开发非侵入性方法, 年轻人可耐受的心血管疾病风险评估3)开发新的药物和/或手术治疗,以降低心血管疾病风险 在青年和4)学习如何最好地参与,激励和培训一系列新兴的研究人员在切割- 边缘POR。作为K24学者的支持将提供专门的时间来从特殊的POR中受益 指导和领导力培训资源,我们的校园和超越,并专注于这些目标。 我的K24应用程序包括概述:1)我的技能,记录和奉献精神,指导在POR; 2) 减少行政/临床义务并专注于指导的战略; 3)有影响力的尖端K24 为受训人员提供大量机会的POR提案; 4)将专家合作者作为一个 K24咨询委员会为初级员工提供上级和有凝聚力的培训、指导和监督 5)有证据表明,有一个强大的受保护的早期职业生涯库, POR研究者将受益于K24的支持; 6)负责开展研究的培训时间轴; 7) 合作者的证据,机构和环境支持我的POR计划和 K24提案。 我作为NHLBI K24学者的目标是:1)加强对早期职业生涯的指导 研究人员创建了一个训练有素的医生,科学家的管道,专注于CVD POR。理由: 拟议的培训计划提供了特殊的支持,环境和专业知识,为创造一个POR的职业生涯在CVD 预防我将把我目前的指导技能与从K24中获得的技能相结合, 质量指导。2)。建立在我的心血管疾病风险降低POR在青年发病肥胖/糖尿病。 理由:鉴于K24的支持,我的定位是提高我们POR研究的质量和广度, 从而改善越来越多的肥胖和糖尿病青年的生活。

项目成果

期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Metabolic outcomes of surgery in youth with type 2 diabetes.
2 型糖尿病青年手术的代谢结果。
  • DOI:
    10.1016/j.sempedsurg.2020.150893
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    1.7
  • 作者:
    Shah,AmyS;Nadeau,KristenJ;Helmrath,MichaelA;Inge,ThomasH;Xanthakos,StavraA;Kelsey,MeganM
  • 通讯作者:
    Kelsey,MeganM
A Model of Adolescent Sleep Health and Risk for Type 2 Diabetes.
  • DOI:
    10.1007/s11892-020-01373-1
  • 发表时间:
    2021-01-15
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Simon SL;Higgins J;Melanson E;Wright KP Jr;Nadeau KJ
  • 通讯作者:
    Nadeau KJ
Early Childhood Caries in Indigenous Communities.
  • DOI:
    10.1542/peds.2021-051481
  • 发表时间:
    2021-06
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Holve S;Braun P;Irvine JD;Nadeau K;Schroth RJ;AMERICAN ACADEMY OF PEDIATRICS COMMITTEE ON NATIVE AMERICAN CHILD HEALTH AND SECTION ON ORAL HEALTH, CANADIAN PAEDIATRIC SOCIETY FIRST NATIONS, INUIT, AND MÉTIS HEALTH COMMITTEE
  • 通讯作者:
    AMERICAN ACADEMY OF PEDIATRICS COMMITTEE ON NATIVE AMERICAN CHILD HEALTH AND SECTION ON ORAL HEALTH, CANADIAN PAEDIATRIC SOCIETY FIRST NATIONS, INUIT, AND MÉTIS HEALTH COMMITTEE
Obstructive sleep apnea and early weight loss among adolescents undergoing bariatric surgery.
Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children.
  • DOI:
    10.1146/annurev-med-042120-012033
  • 发表时间:
    2022-01-27
  • 期刊:
  • 影响因子:
    10.5
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KRISTEN Jane NADEAU其他文献

KRISTEN Jane NADEAU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KRISTEN Jane NADEAU', 18)}}的其他基金

The Next Generation of Innovative Cardiovascular Clinical/Translational Researchers
下一代创新型心血管临床/转化研究人员
  • 批准号:
    10327672
  • 财政年份:
    2019
  • 资助金额:
    $ 11.49万
  • 项目类别:
RISE: The Restoring Insulin Secretion Pediatric Medication Study
RISE:恢复胰岛素分泌的儿科药物研究
  • 批准号:
    8893072
  • 财政年份:
    2011
  • 资助金额:
    $ 11.49万
  • 项目类别:
Beta-Cell Rescue in Youth with New Onset T2DM
β 细胞拯救新发 T2DM 青少年
  • 批准号:
    8336912
  • 财政年份:
    2011
  • 资助金额:
    $ 11.49万
  • 项目类别:
Beta-Cell Rescue in Youth with New Onset T2DM
β 细胞拯救新发 T2DM 青少年
  • 批准号:
    8536282
  • 财政年份:
    2011
  • 资助金额:
    $ 11.49万
  • 项目类别:
RISE: The Restoring Insulin Secretion Pediatric Medication Study
RISE:恢复胰岛素分泌的儿科药物研究
  • 批准号:
    9109755
  • 财政年份:
    2011
  • 资助金额:
    $ 11.49万
  • 项目类别:
Beta-Cell Rescue in Youth with New Onset T2DM
β 细胞拯救新发 T2DM 青少年
  • 批准号:
    8248477
  • 财政年份:
    2011
  • 资助金额:
    $ 11.49万
  • 项目类别:
Beta-cell Rescue in Youth with New Onset T2DM
β 细胞拯救新发 T2DM 青少年
  • 批准号:
    8331068
  • 财政年份:
    2011
  • 资助金额:
    $ 11.49万
  • 项目类别:
RISE: The Restoring Insulin Secretion Pediatric Medication Study
RISE:恢复胰岛素分泌的儿科药物研究
  • 批准号:
    8703096
  • 财政年份:
    2011
  • 资助金额:
    $ 11.49万
  • 项目类别:
Insulin Resistance In Adolescents With Diabetes: A New Frontier For Cardiovascula
青少年糖尿病患者的胰岛素抵抗:心血管的新领域
  • 批准号:
    8074154
  • 财政年份:
    2010
  • 资助金额:
    $ 11.49万
  • 项目类别:
EXERCISE CAPACITY IN PEDIATRIC OBESITY AND TYPE 2 DIABETES
儿童肥胖和 2 型糖尿病患者的运动能力
  • 批准号:
    7605088
  • 财政年份:
    2007
  • 资助金额:
    $ 11.49万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 11.49万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 11.49万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.49万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.49万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 11.49万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.49万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 11.49万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 11.49万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 11.49万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.49万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了